On August 20, 2026 Adagene Inc. (Nasdaq: ADAG) a platform-driven, clinical-stage biotechnology company transforming the discovery and development of novel antibody-based therapies, reported that senior management will participate in three upcoming investor conferences taking place in New York, New York.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

2026 Cantor Global Healthcare Conference; New York, NY – September 9-11, 2026

Format: 1×1 Meetings
Date/Time: September 11, 2026
Morgan Stanley 24th Annual Global Healthcare Conference; New York, NY – September 14-16, 2026

Format: Fireside Chat and 1×1 Meetings
Fireside Chat Date/Time: September 15, 2026, 10:45–11:20 AM (Eastern Time)
H.C. Wainwright 28th Annual Global Investment Conference; New York, NY – September 14-16, 2026

Format: Fireside Chat and 1×1 Meetings
Fireside Chat Date/Time: September 16, 2026, 9:00–9:30 AM (Eastern Time)
If you are interested in meeting with Adagene management during the conferences, please reach out to your representative for each respective conference.

Webcasts of the fireside chats will be accessible in the Investors section of the Company’s website at View Source for at least 30 days following each of the conferences.

(Press release, Adagene, AUG 20, 2026, View Source [SID1234670266])